View in EDS HTML Full Text PDF Full Text

Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.

Saved in:
Bibliographic Details
Title: Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.
Authors: Lopez-Mejia IC; Center for Integrative Genomics, University of Lausanne, Switzerland., Pijuan J; Laboratory of Neurogenetics and Molecular Medicine - Pediatric Institute of Rare Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Navaridas R; Departament de Ciències Mèdiques Bàsiques, IRBLleida, University of Lleida, Spain., Santacana M; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain., Gatius S; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain., Velasco A; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain., Castellà G; Biostatistics Unit, Hospital Universitari Arnau de Vilanova, IRB-Lleida, University of Lleida, Spain., Panosa A; Flow Cytometry and Confocal Microscopy Unit, IRBLleida, University of Lleida, Spain., Cabiscol E; Departament de Ciències Mèdiques Bàsiques, IRBLleida, University of Lleida, Spain., Pinyol M; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain., Coll L; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain., Bonifaci N; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Peña LP; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain., Vidal A; Department of Pathology-Hospital, Universitari de Bellvitge, Barcelona, Spain.; Xenopat S.L., Parc Cientific de Barcelona (PCB), Spain., Villanueva A; Xenopat S.L., Parc Cientific de Barcelona (PCB), Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), ICO, IDIBELL, Barcelona, Spain., Gari E; Departament de Ciències Mèdiques Bàsiques, IRBLleida, University of Lleida, Spain., Llobet-Navàs D; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Fajas L; Center for Integrative Genomics, University of Lausanne, Switzerland., Matias-Guiu X; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Pathology-Hospital, Universitari de Bellvitge, Barcelona, Spain., Yeramian A; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.
Source: Molecular oncology [Mol Oncol] 2023 Jan; Vol. 17 (1), pp. 98-118. Date of Electronic Publication: 2022 Dec 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36409196
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lopez-Mejia+IC%22">Lopez-Mejia IC</searchLink>; Center for Integrative Genomics, University of Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pijuan+J%22">Pijuan J</searchLink>; Laboratory of Neurogenetics and Molecular Medicine - Pediatric Institute of Rare Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Navaridas+R%22">Navaridas R</searchLink>; Departament de Ciències Mèdiques Bàsiques, IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Santacana+M%22">Santacana M</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Gatius+S%22">Gatius S</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Velasco+A%22">Velasco A</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Castellà+G%22">Castellà G</searchLink>; Biostatistics Unit, Hospital Universitari Arnau de Vilanova, IRB-Lleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Panosa+A%22">Panosa A</searchLink>; Flow Cytometry and Confocal Microscopy Unit, IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Cabiscol+E%22">Cabiscol E</searchLink>; Departament de Ciències Mèdiques Bàsiques, IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Pinyol+M%22">Pinyol M</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Coll+L%22">Coll L</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bonifaci+N%22">Bonifaci N</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Peña+LP%22">Peña LP</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal+A%22">Vidal A</searchLink>; Department of Pathology-Hospital, Universitari de Bellvitge, Barcelona, Spain.; Xenopat S.L., Parc Cientific de Barcelona (PCB), Spain.<br /><searchLink fieldCode="AU" term="%22Villanueva+A%22">Villanueva A</searchLink>; Xenopat S.L., Parc Cientific de Barcelona (PCB), Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), ICO, IDIBELL, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gari+E%22">Gari E</searchLink>; Departament de Ciències Mèdiques Bàsiques, IRBLleida, University of Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Llobet-Navàs+D%22">Llobet-Navàs D</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fajas+L%22">Fajas L</searchLink>; Center for Integrative Genomics, University of Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Matias-Guiu+X%22">Matias-Guiu X</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran via de l'Hospitalet, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Pathology-Hospital, Universitari de Bellvitge, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Yeramian+A%22">Yeramian A</searchLink>; Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova (HUAV), IRBLleida, University of Lleida, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2023 Jan; Vol. 17 (1), pp. 98-118. <i>Date of Electronic Publication: </i>2022 Dec 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36409196
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13346
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 98
    Titles:
      – TitleFull: Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lopez-Mejia IC
      – PersonEntity:
          Name:
            NameFull: Pijuan J
      – PersonEntity:
          Name:
            NameFull: Navaridas R
      – PersonEntity:
          Name:
            NameFull: Santacana M
      – PersonEntity:
          Name:
            NameFull: Gatius S
      – PersonEntity:
          Name:
            NameFull: Velasco A
      – PersonEntity:
          Name:
            NameFull: Castellà G
      – PersonEntity:
          Name:
            NameFull: Panosa A
      – PersonEntity:
          Name:
            NameFull: Cabiscol E
      – PersonEntity:
          Name:
            NameFull: Pinyol M
      – PersonEntity:
          Name:
            NameFull: Coll L
      – PersonEntity:
          Name:
            NameFull: Bonifaci N
      – PersonEntity:
          Name:
            NameFull: Peña LP
      – PersonEntity:
          Name:
            NameFull: Vidal A
      – PersonEntity:
          Name:
            NameFull: Villanueva A
      – PersonEntity:
          Name:
            NameFull: Gari E
      – PersonEntity:
          Name:
            NameFull: Llobet-Navàs D
      – PersonEntity:
          Name:
            NameFull: Fajas L
      – PersonEntity:
          Name:
            NameFull: Matias-Guiu X
      – PersonEntity:
          Name:
            NameFull: Yeramian A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023 Jan
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1